Immunology

New therapeutic approach for advanced lung disease

Researchers have demonstrated the potential of a new class of drugs for the treatment of refractory chronic obstructive pulmonary disease (COPD). Incurable to date, the disease is one of the most frequent causes of death ...

Parkinson's & Movement disorders

Identifying another piece in the Parkinson's disease pathology puzzle

An international public-private research consortium has identified and validated a cellular role of a primary Parkinson's disease drug target, the LRRK2 kinase. This important finding, published in the online, open-access ...

Oncology & Cancer

Clearing a path for cancer research

EMBL-EBI researchers have developed a new computational method to study biological signalling networks in healthy and cancer cells.

Medical research

Cancer-fighting drugs might also stop malaria early

Scientists searching for new drugs to fight malaria have identified a number of compounds—some of which are currently in clinical trials to treat cancer—that could add to the anti-malarial arsenal.

Oncology & Cancer

Alternative target for breast cancer drugs

Scientists have identified higher levels of a receptor protein found on the surface of human breast tumour cells that may serve as a new drug target for the treatment of breast cancer. The results, which are published today ...

Oncology & Cancer

Clinical trial delivers good results in leukemia patients

Huntsman Cancer Institute (HCI) researchers Michael Deininger, M.D., Ph.D., and Thomas O'Hare, Ph.D., were part of a team that found a potent oral drug, ponatinib, effective in patients who have developed resistance to standard ...

Medications

Popular antidepressant might prevent heart failure

A medication usually used to help treat depression and anxiety disorders has the potential to help prevent heart failure, according to researchers at the University of Michigan.

page 3 from 4